findmyKOL

Nauman Tariq, MD

Basic profile

Atrium Health Wake Forest Baptist

ORCIDNone on fileNPI
RegionCharlotte, NC · SoutheastSpecialtyNeurologyFocusNeurology
Last active 2022findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2022Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Nauman Tariq is a Neurology physician affiliated with Atrium Health Wake Forest Baptist. OpenAlex indexes 89 publications with 2,305 citations (h-index 24); ClinicalTrials.gov lists 2 registered studies matched to this name.

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
89publications

Distinct works indexed by OpenAlex.

2,305citations

Total citations across indexed works.

24h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
2clinical trials

Investigator role on registered studies.

View trials
2companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1225 Harding Pl
Ste 4100
Charlotte, NC 282042826

Telephone

704-377-9323

Registry record last updated 15 Jul 2024.

View the NPPES registry record

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Industry payments

2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Nervous system

    73.5%
    Serotonin-1b and Serotonin-1d Receptor Agonist21.1%
    Rizatriptan50%Sumatriptan Succinate19%Naratriptan Hcl18%Eletriptan Hbr13%
    Part D52 patients
    Calcitonin gene-related peptide (CGRP) antagonists13.2%
    Emgality Pen52%Aimovig Autoinjector21%Emgality Syringe19%Ajovy Autoinjector8%
    Part D<11 patients

    + 10 more classes in this area

  • Sensory organs

    9.5%
    Corticosteroid9.5%
    Dexamethasone sodium phosphate100%
    Part B, office-administered18 patients
  • Musculoskeletal

    8.5%
    gamma-Aminobutyric Acid-ergic Agonist4.7%
    Baclofen100%
    Part D24 patients
    Cyclooxygenase Inhibitor1.9%
    Ketorolac Tromethamine100%
    Part D<11 patients

    + 2 more classes in this area

Where care is delivered (Part B)18.6% facility · 81.4% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”